To evaluate the safety and tolerability of Phenlarmide tablets in patients with Parkinson's disease in the early and middle stages.
To evaluate the pharmacokinetics of Phenlarmide tablets in patients with Parkinson's disease.
To explore the efficacy of Phenlarmide tablets in the treatment of early and mid-term Parkinson's disease.